Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tumor-like proliferation of CCM3 knockout endothelial cells: Insights from semaxinib treatment and transcriptome profiling of co-cultures

ABSTRACT: We used RNA-seq to study the effect of semaxinib treatment on induced pluripotent stem cell (iPSC)-derived wild-type (WT) and CCM3 knockout (KO) endothelial cells (iEC) in co-culture.

ORGANISM(S): Homo sapiens

PROVIDER: GSE310745 | GEO | 2026/04/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Tumor-like proliferation of CCM3 knockout endothelial cells: Insights from semaxinib treatment and transcriptome profiling of co-cultures

Project description:Tumor-like proliferation of CCM3 knockout endothelial cells: Insights from semaxinib treatment and transcriptome profiling of co-cultures

| PRJNA1367022 | ENA

CRISPR/Cas9 genome editing demonstrates that CCM3 modulates endothelial miRNA expression

Project description:CCM3 regulates blood-brain-barrier integrity and vascular maturation in vivo. CCM3 loss-of-function variants predispose to cerebral cavernous malformations (CCM). Various signalling pathways are deregulated upon CCM3 depletion in endothelial cells (ECs). In this study, we established a crRNA:tracrRNA:Cas9 RNP approach to efficiently knockout CCM3 in human ECs and studied the molecular and functional effects of its long-term inactivation. Using small RNA sequencing, we show that CCM3 regulates the expression of aging‑associated miRNAs.

2019-01-18 | GSE114947 | GEO

mRNA expression changes in CCM3-deficient endothelial cells

Project description:Loss-of-function variants in CCM3/PDCD10 predispose to cerebral cavernous malformations (CCMs) that are vascular lesion of the central nervous system. Using CRISPR/Cas9 genome editing and RNA sequencing, we have shown that long-term inactivation of CCM3 in human endothelial cells dysregulates fibronectin expression and thus impairs the assembly of a functional fibronectin matrix by endothelial cells.

2020-07-06 | GSE137425 | GEO

Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells.

Project description: Not available

| S-EPMC9166869 | biostudies-literature

RNA-seq of wild-type and Ccm3 knock-out mouse cerebellar endothelial cells

Project description:The purpose of this study was to investigate the transcriptional regulation of endothelial cells in CCM pathology. We isolated cerebellar endothelial cells from healthy (wild-type) mice and from mice with an inducible endothelial-specific knock-out of the Ccm3 gene (Ccm3 knock-out). We prepared RNA libraries and sequenced the samples on a HiSeq2500 sequencing system with v4 chemistry from Illumina. We then performed a differential gene expression analysis to identify genes that play a role in CCM pathology.

2022-11-22 | GSE212018 | GEO

mRNA expression changes in CCM3-deficient endothelial cells

Project description:mRNA expression changes in CCM3-deficient endothelial cells

| PRJNA565417 | ENA

CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling

Project description:We report that loss of CCM3/PDCD10 in fibroblasts induces FAK/Src-paxillin signalling driving actomyosin-dependent mechanotransduction leading to YAP/TAZ signalling. In vivo, loss of CCM3 in fibroblasts drives excessive tissue remodelling leading to the dissemination of breast cancer cells to distant organs.

2021-05-06 | GSE155688 | GEO

The fibronectin mediated endothelial rescue effect in CCM3-deficient cells is independent from acute mRNA changes

Project description:Using CRISPR/Cas9 genome editing and RNA sequencing, we demonstrate that fibronectin supplementation restores the impaired spheroid formation and attenuates actin stress fiber assembly in CCM3-/- endothelial cells independently of acute gene expression differences. In particular, there was no significant downregulation of well-known key players in CCM pathogenesis like KLF2 or KLF4.

2020-07-06 | GSE137426 | GEO

Early and late passage endothelial cells with or without PDCD10 downregulation

Project description:Primary cells deficient for PDCD10/CCM3 do not enter senescence as control cells. Microarray analysis was performed in cells transduced with non-targeting shRNA and CCM3 shRNA at passage 7 (early passage) and passage 11 (late passage), when control cells are already senescent. Primary endothelial cells were transduced either with non-target shRNA or with CCM3 shRNA. RNA was extracted at passage 7 and passage 11

2014-04-10 | E-GEOD-54095 | biostudies-arrayexpress

CRISPR/Cas9 genome editing demonstrates that CCM3 modulates endothelial miRNA expression

Project description:CRISPR/Cas9 genome editing demonstrates that CCM3 modulates endothelial miRNA expression

| PRJNA473162 | ENA